Disclosure Intervention for People in Recovery From Opioid Use Disorder
NCT ID: NCT04836247
Last Updated: 2024-01-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-07-26
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Disclosure Intervention for People in Treatment for Opioid Use Disorder
NCT06458985
Peer Recovery Coaching for Tobacco Abstinence in People With Opioid Use Disorder
NCT06965153
Substance Use Treatment and Recovery Team
NCT05086796
Preventing OUD in Justice-Involved Youth
NCT04901312
Women's Treatment and Early Recovery
NCT02977988
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Disclosure Intervention Arm
Participants will be guided through a workbook and accompanying worksheet designed to help them: (1) decide whether or not they want to share information about their substance use with others, and (2) build skills for disclosing (e.g., planning what to say). Importantly, the intervention is not designed to encourage participants to disclose or not disclose, but rather to help participants decide whether they want to disclose based on their own goals and values.
Disclosing Recovery: A Decision Aid and Toolkit
Participants will be guided through a workbook and accompanying worksheet designed to help them: (1) decide whether or not they want to share information about their substance use with others, and (2) build skills for disclosing (e.g., planning what to say). Importantly, the intervention is not designed to encourage participants to disclose or not disclose, but rather to help participants decide whether they want to disclose based on their own goals and values.
Control Arm
Participants will be able to choose from several guided meditations to promote mindfulness.
Mindfulness
Participants will be able to choose from several guided meditations to promote mindfulness
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Disclosing Recovery: A Decision Aid and Toolkit
Participants will be guided through a workbook and accompanying worksheet designed to help them: (1) decide whether or not they want to share information about their substance use with others, and (2) build skills for disclosing (e.g., planning what to say). Importantly, the intervention is not designed to encourage participants to disclose or not disclose, but rather to help participants decide whether they want to disclose based on their own goals and values.
Mindfulness
Participants will be able to choose from several guided meditations to promote mindfulness
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* currently receiving outpatient treatment at the recruitment site
* are considering disclosing their recovery status to at least one person in the next month
* have access to a phone that can receive text messages and phone calls
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Drug Abuse (NIDA)
NIH
Massachusetts General Hospital
OTHER
Harvard School of Public Health (HSPH)
OTHER
Harvard Medical School (HMS and HSDM)
OTHER
University of Delaware
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Valerie Earnshaw
Associate Professor of Human Development and Family Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brandywine Counseling and Community Services
Wilmington, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Earnshaw VA, Sepucha KR, Laurenceau JP, Subramanian SV, Hill EC, Wallace J, Brousseau NM, Henderson C, Brohan E, Morrison LM, Kelly JF. Disclosing Recovery: A pilot randomized controlled trial of a patient decision aid to improve disclosure processes for people in treatment for opioid use disorder. J Subst Use Addict Treat. 2024 May;160:209291. doi: 10.1016/j.josat.2024.209291. Epub 2024 Jan 23.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.